indirubin has been researched along with paclitaxel in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Aggarwal, BB; Ahn, KS; Chaturvedi, MM; Lin, X; Sandur, SK; Sethi, G | 1 |
2 other study(ies) available for indirubin and paclitaxel
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Line; Cell Line, Tumor; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Synergism; Growth Inhibitors; Humans; I-kappa B Kinase; Indoles; NF-kappa B; Paclitaxel; Phosphorylation; Protein Binding; Signal Transduction; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2006 |